相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD)
Janet Hardy et al.
JOURNAL OF CLINICAL ONCOLOGY (2023)
The Effect of Cannabis Plant Extracts on Head and Neck Squamous Cell Carcinoma and the Quest for Cannabis-Based Personalized Therapy
Kifah Blal et al.
CANCERS (2023)
The protective effect of cannabinoids against colorectal cancer cachexia through modulation of inflammation and immune responses
Shang-Kok Ng et al.
BIOMEDICINE & PHARMACOTHERAPY (2023)
Multinational Association of Supportive Care in Cancer (MASCC) guidelines: cannabis for psychological symptoms including insomnia, anxiety, and depression
Giulia De Feo et al.
SUPPORTIVE CARE IN CANCER (2023)
Mechanisms of cancer pain
Rayan Haroun et al.
FRONTIERS IN PAIN RESEARCH (2023)
Cannabis and Psychosis: Recent Epidemiological Findings Continuing the Causality Debate
Suhas Ganesh et al.
AMERICAN JOURNAL OF PSYCHIATRY (2022)
PerspectivesRe-legalizing cannabis for medical use in the USA
Brenda Victor et al.
JOURNAL OF PUBLIC HEALTH (2022)
The Safety of Dronabinol and Nabilone: A Systematic Review and Meta-Analysis of Clinical Trials
Akos Bajtel et al.
PHARMACEUTICALS (2022)
Long-Term Cannabis Use and Cognitive Reserves and Hippocampal Volume in Midlife
Madeline H. Meier et al.
AMERICAN JOURNAL OF PSYCHIATRY (2022)
Routes of administration, reasons for use, and approved indications of medical cannabis in oncology: a scoping review
Billy Vinette et al.
BMC CANCER (2022)
Cannabinoids as anticancer drugs: current status of preclinical research
Burkhard Hinz et al.
BRITISH JOURNAL OF CANCER (2022)
Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer?
Sarah Lord et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2022)
Exploration of Multiverse Activities of Endocannabinoids in Biological Systems
Tapan Behl et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Management of common clinical problems experienced by survivors of cancer
Jon Emery et al.
LANCET (2022)
The Medicinal Natural Products of Cannabis sativa Linn.: A Review
Anwuli Endurance Odieka et al.
MOLECULES (2022)
Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies
Suzanne Nielsen et al.
NEUROPSYCHOPHARMACOLOGY (2022)
Inhaled Marijuana and the Lung
Donald P. Tashkin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)
Unacceptable pain in oncology: The patients' perspective on reasons for absence of pain interventions
Hester Stoorvogel et al.
EUROPEAN JOURNAL OF CANCER CARE (2022)
Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications
Ainhoa Bilbao et al.
BMC MEDICINE (2022)
Marijuana and the Lung Evolving Understandings
Manish Joshi et al.
MEDICAL CLINICS OF NORTH AMERICA (2022)
Use of Cannabis and Cannabinoids for Treatment of Cancer
Viktoriia Cherkasova et al.
CANCERS (2022)
The effect of medical cannabis on cognitive functions: a systematic review
Anders Wieghorst et al.
SYSTEMATIC REVIEWS (2022)
Cannabis, Cannabinoids and Cannabis-Based Medicines in Cancer Care Comment
Donald I. Abrams
INTEGRATIVE CANCER THERAPIES (2022)
Medical cannabis regulation: an overview of models around the world with emphasis on the Brazilian scenario
Maira Ribeiro de Souza et al.
JOURNAL OF CANNABIS RESEARCH (2022)
The Effectiveness and Safety of Medical Cannabis for Treating Cancer Related Symptoms in Oncology Patients
Joshua Aviram et al.
FRONTIERS IN PAIN RESEARCH (2022)
Cannabis suppresses antitumor immunity by inhibiting JAK/STAT signaling in T cells through CNR2
Xinxin Xiong et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)
Cannabis as an Anticancer Agent: A Review of Clinical Data and Assessment of Case Reports
Jordan Guggisberg et al.
CANNABIS AND CANNABINOID RESEARCH (2022)
Discontinuing cannabis improves depression in people with multiple sclerosis: A short report
Anthony Feinstein et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Physicians' experiences, attitudes, and beliefs towards medical cannabis: a systematic literature review
Sabrina Trappaud Ronne et al.
BMC FAMILY PRACTICE (2021)
Cannabis-Derived Compounds Cannabichromene and Δ9-Tetrahydrocannabinol Interact and Exhibit Cytotoxic Activity against Urothelial Cell Carcinoma Correlated with Inhibition of Cell Migration and Cytoskeleton Organization
Omer Anis et al.
MOLECULES (2021)
ACPA decreases non-small cell lung cancer line growth through Akt/PI3K and JNK pathways in vitro
OEzge Boyacioglu et al.
CELL DEATH & DISEASE (2021)
Synthetic Cannabinoids Induce Autophagy and Mitochondrial Apoptotic Pathways in Human Glioblastoma Cells Independently of Deficiency in TP53 or PTEN Tumor Suppressors
Aleksandra Ellert-Miklaszewska et al.
CANCERS (2021)
Inhaled Cannabis Suppresses Chemotherapy-Induced Neuropathic Nociception by Decoupling the Raphe Nucleus: A Functional Imaging Study in Rats
Ilayda Alkislar et al.
BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING (2021)
Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4
Tengfei Huang et al.
AUTOPHAGY (2021)
A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma
Chris Twelves et al.
BRITISH JOURNAL OF CANCER (2021)
Cannabis, Vaping, and Respiratory Symptoms in a Probability Sample of US Youth
Carol J. Boyd et al.
JOURNAL OF ADOLESCENT HEALTH (2021)
Cannabidiol Interactions with Medications, Illicit Substances, and Alcohol: a Comprehensive Review
Premalatha Balachandran et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2021)
Cannabis use and cannabis use disorder
Jason P. Connor et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
THC Reduces Ki67-Immunoreactive Cells Derived from Human Primary Glioblastoma in a GPR55-Dependent Manner
Marc Richard Kolbe et al.
CANCERS (2021)
The relationship between cannabis and schizophrenia: a genetically informed perspective
Emma C. Johnson et al.
ADDICTION (2021)
Cyclin-Dependent Kinase Inhibitors and Their Therapeutic Potential in Colorectal Cancer Treatment
Oana-Maria Thoma et al.
FRONTIERS IN PHARMACOLOGY (2021)
Molecular Mechanism of Cannabinoids in Cancer Progression
Cristina Pagano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors?
Leontina Elena Filipiuc et al.
PHARMACEUTICS (2021)
The Potential Use of Cannabis in Tissue Fibrosis
Nazar Pryimak et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Pharmacological and Toxicological Effects of Phytocannabinoids and Recreational Synthetic Cannabinoids: Increasing Risk of Public Health
Vidyasagar Naik Bukke et al.
PHARMACEUTICALS (2021)
Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies
David P. Finn et al.
PAIN (2021)
Cancer Cachexia: Its Mechanism and Clinical Significance
Hiroki Nishikawa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Cannabinoids in the landscape of cancer
Nagina Mangal et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
Inhibition of autophagic flux differently modulates cannabidiol-induced death in 2D and 3D glioblastoma cell cultures (vol 10, 2687, 2020)
Vladimir N. Ivanov et al.
SCIENTIFIC REPORTS (2021)
Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials
Li Wang et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline
Jason W. Busse et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use in an Observational Trial
Erin L. Martin et al.
FRONTIERS IN PSYCHIATRY (2021)
A Phase 2 Randomised Clinical Trial Assessing the Tolerability of Two Different Ratios of Medicinal Cannabis in Patients With High Grade Gliomas
Janet Schloss et al.
FRONTIERS IN ONCOLOGY (2021)
Shape Matters: Plant Architecture Affects Chemical Uniformity in Large-Size Medical Cannabis Plants
Nadav Danziger et al.
PLANTS-BASEL (2021)
Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines
J. Arends et al.
ESMO OPEN (2021)
Topical Cannabinoids for Treating Chemotherapy-Induced Neuropathy: A Case Series
Stacy D'Andre et al.
INTEGRATIVE CANCER THERAPIES (2021)
A Review of Hemp as Food and Nutritional Supplement
Pellegrino Cerino et al.
CANNABIS AND CANNABINOID RESEARCH (2021)
Effect of cannabis on oxaliplatin-induced peripheral neuropathy among oncology patients: a retrospective analysis
Barliz Waissengrin et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2021)
Depression and anxiety in long-term survivors 5 and 10 years after cancer diagnosis
Heide Goetze et al.
SUPPORTIVE CARE IN CANCER (2020)
Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies
Yun-He Wang et al.
MOLECULAR PSYCHIATRY (2020)
Treatment with Cannabinoids as a Promising Approach for Impairing Fibroblast Activation and Prostate Cancer Progression
Laura Pietrovito et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The Endocannabinoid System Alleviates Pain in a Murine Model of Cancer-Induced Bone Pain
A. L. Thompson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)
Challenges and Opportunities in Preclinical Research of Synthetic Cannabinoids for Pain Therapy
Bogdan Ionel Tamba et al.
MEDICINA-LITHUANIA (2020)
Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro
Lara Milian et al.
PLOS ONE (2020)
Secondary Metabolites Profiled in Cannabis Inflorescences, Leaves, Stem Barks, and Roots for Medicinal Purposes
Dan Jin et al.
SCIENTIFIC REPORTS (2020)
CBD Reverts the Mesenchymal Invasive Phenotype of Breast Cancer Cells Induced by the Inflammatory Cytokine IL-1β
Lazaro Garcia-Morales et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Management of Cancer Cachexia: ASCO Guideline
Eric J. Roeland et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Herbal Preparations of Medical Cannabis: A Vademecum for Prescribing Doctors
Pietro Brunetti et al.
MEDICINA-LITHUANIA (2020)
Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial
P. Grimison et al.
ANNALS OF ONCOLOGY (2020)
Win 55,212-2, atenolol and subdiaphragmatic vagotomy prevent acceleration of gastric emptying induced by cachexia via Yoshida-AH-130 cells in rats
Mickael Laudrup de Sousa Cavalcante et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Medical Care Costs Associated with Cancer Survivorship in the United States
Angela B. Mariotto et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
Charles L. Loprinzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Cannabinoids and Cannabinoid Receptors: The Story so Far
Fred Shahbazi et al.
ISCIENCE (2020)
The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises
Srinivasa N. Raja et al.
PAIN (2020)
TRPM8 channels: A review of distribution and clinical role
Yuqian Liu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties
Lara Sharpe et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids
Dennis J. Sholler et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)
Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome
Gil Bar-Sela et al.
CANCERS (2020)
Targeting CYP2J2 to Enhance the Anti-Glioma Efficacy of Cannabinoid Receptor 2 Stimulation by Inhibiting the Pro-Angiogenesis Function of M2 Microglia
Xuejiao Lei et al.
FRONTIERS IN ONCOLOGY (2020)
Nutritional Interventions in Cancer Cachexia: Evidence and Perspectives From Experimental Models
Wouter R. P. H. van de Worp et al.
FRONTIERS IN NUTRITION (2020)
Cannabinoids Inhibited Pancreatic Cancer via P-21 Activated Kinase 1 Mediated Pathway
Yang Yang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The endocannabinoid system in modulating fear, anxiety, and stress
Rafael Maldonado et al.
DIALOGUES IN CLINICAL NEUROSCIENCE (2020)
An Overview of Current Recommendations and Options for the Management of Cancer Pain: A Comprehensive Review
Kyle L. Gress et al.
ONCOLOGY AND THERAPY (2020)
History of cannabis and the endocannabinoid system
Marc-Antoine Crocq
DIALOGUES IN CLINICAL NEUROSCIENCE (2020)
Chemotherapy-Induced Peripheral Neuropathy: Causative Agents, Preventative Strategies, and Treatment Approaches
Rishi Kachrani et al.
JOURNAL OF PAIN & PALLIATIVE CARE PHARMACOTHERAPY (2020)
The effectiveness of inhaled Cannabis flower for the treatment of agitation/irritability, anxiety, and common stress
Sarah S. Stith et al.
JOURNAL OF CANNABIS RESEARCH (2020)
Medical cannabis use in the United States: a retrospective database study
V. Kishan Mahabir et al.
JOURNAL OF CANNABIS RESEARCH (2020)
A Brief Background on Cannabis: From Plant to Medical Indications
Linda E. Klumpers et al.
JOURNAL OF AOAC INTERNATIONAL (2019)
Cannabinoid WIN 55,212-2 induces cell cycle arrest and apoptosis, and inhibits proliferation, migration, invasion, and tumor growth in prostate cancer in a cannabinoid-receptor 2 dependent manner
Domenica Roberto et al.
PROSTATE (2019)
Δ9-Tetrahydrocannabinol upregulates fatty acid 2-hydroxylase (FA2H) via PPARα induction: A possible evidence for the cancellation of PPARβ/δ-mediated inhibition of PPARα in MDA-MB-231 cells
Masayo Hirao-Suzuki et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2019)
Mediators of cachexia in cancer patients
Josep M. Argiles et al.
NUTRITION (2019)
Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer
Sandra Blasco-Benito et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
MDA19, a novel CB2 agonist, inhibits hepatocellular carcinoma partly through inactivation of AKT signaling pathway
Mei Rao et al.
BIOLOGY DIRECT (2019)
The Use of Cannabinoids for Sleep: A Critical Review on Clinical Trials
Nirushi Kuhathasan et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2019)
Cancer Pain and Quality of Life
Carmen Rodriguez et al.
JOURNAL OF HOSPICE & PALLIATIVE NURSING (2019)
Efficacy, tolerability and safety of cannabis-based medicines for cancer pain A systematic review with meta-analysis of randomised controlled trials
Winfried Haeuser et al.
SCHMERZ (2019)
Chemotherapy-induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol
Daniel I. Brierley et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
Estefania Moreno et al.
FRONTIERS IN PHARMACOLOGY (2019)
The role of 2-arachidonoylglycerol in the regulation of the tumor-immune microenvironment in murine models of pancreatic cancer
Chongyang Qiu et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Cannabidiol Adverse Effects and Toxicity
Marilyn A. Huestis et al.
CURRENT NEUROPHARMACOLOGY (2019)
Marijuana Use in Pregnancy: A Review
Rebecca Thompson et al.
OBSTETRICAL & GYNECOLOGICAL SURVEY (2019)
Akt in cancer: Mediator and more
Sundaramoorthy Revathidevi et al.
SEMINARS IN CANCER BIOLOGY (2019)
Cannabidiol Induces Cell Cycle Arrest and Cell Apoptosis in Human Gastric Cancer SGC-7901 Cells
Xin Zhang et al.
BIOMOLECULES (2019)
Allosteric modulators targeting cannabinoid cb1 and cb2 receptors: implications for drug discovery
Francesca Gado et al.
FUTURE MEDICINAL CHEMISTRY (2019)
Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority
Claire L. Niedzwiedz et al.
BMC CANCER (2019)
Apical bud removal increased seed yield in hemp (Cannabis sativa L.)
Darja Kocjan Acko et al.
ACTA AGRICULTURAE SCANDINAVICA SECTION B-SOIL AND PLANT SCIENCE (2019)
2-APB and CBD-Mediated Targeting of Charged Cytotoxic Compounds Into Tumor Cells Suggests the Involvement of TRPV2 Channels
Hagit Neumann-Raizel et al.
FRONTIERS IN PHARMACOLOGY (2019)
Cannabidiol-induced apoptosis is mediated by activation of Noxa in human colorectal cancer cells
Soyeon Jeong et al.
CANCER LETTERS (2019)
Cannabis Impacts Tumor Response Rate to Nivolumab in Patients with Advanced Malignancies
Tarek Taha et al.
ONCOLOGIST (2019)
Role of miRNA in the regulation of cannabidiol-mediated apoptosis in neuroblastoma cells
Esraah Alharris et al.
Oncotarget (2019)
Health-related quality of life across cancer cachexia stages
Popi Kasvis et al.
ANNALS OF PALLIATIVE MEDICINE (2019)
Association Between Marijuana Use and Risk of Cancer A Systematic Review and Meta-analysis
Mehrnaz Ghasemiesfe et al.
JAMA NETWORK OPEN (2019)
Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines
M. Fallon et al.
ANNALS OF ONCOLOGY (2018)
AT 101 induces early mitochondrial dysfunction and HMOX1 (heme oxygenase 1) to trigger mitophagic cell death in glioma cells
Nina Meyer et al.
AUTOPHAGY (2018)
Appraising the entourage effect: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer
Sandra Blasco-Benito et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Cannabinoids and cancer pain: A new hope or a false dawn?
Matthew R. D. Brown et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
Medical use of cannabis and cannabinoids containing products - Regulations in Europe and North America
Ran Abuhasira et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
Medical Oncologists' Beliefs, Practices, and Knowledge Regarding Marijuana Used Therapeutically: A Nationally Representative Survey Study
Ilana M. Braun et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain
Aron H. Lichtman et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2018)
Cannabinoid-induced cell death in endometrial cancer cells: involvement of TRPV1 receptors in apoptosis
B. M. Fonseca et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2018)
The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial
Jenny G. Turcott et al.
SUPPORTIVE CARE IN CANCER (2018)
Dronabinol oral solution in the management of anorexia and weight loss in AIDS and cancer
Melissa E. Badowski et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2018)
Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide
Israel Lopez-Valero et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Cannabinoid Delivery Systems for Pain and Inflammation Treatment
Natascia Bruni et al.
MOLECULES (2018)
Targeting the Endocannabinoid System for Prevention or Treatment of Chemotherapy-Induced Neuropathic Pain: Studies in Animal Models
Willias Masocha
PAIN RESEARCH & MANAGEMENT (2018)
Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer
Uchini S. Kosgodage et al.
FRONTIERS IN PHARMACOLOGY (2018)
A Public Health Strategy for the Opioid Crisis
Brendan Saloner et al.
PUBLIC HEALTH REPORTS (2018)
A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
Sophie A. Millar et al.
FRONTIERS IN PHARMACOLOGY (2018)
Identification of Synergistic Interaction Between Cannabis-Derived Compounds for Cytotoxic Activity in Colorectal Cancer Cell Lines and Colon Polyps That Induces Apoptosis-Related Cell Death and Distinct Gene Expression
Rameshprabu Nallathambi et al.
CANNABIS AND CANNABINOID RESEARCH (2018)
Focus on Cannabinoids and Synthetic Cannabinoids
R. Le Boisselier et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Patients' perception of chemotherapy side effects: Expectations, doctor-patient communication and impact on quality of life - An Italian survey
Domenica Lorusso et al.
EUROPEAN JOURNAL OF CANCER CARE (2017)
Cannabinoid derivatives exert a potent anti-myeloma activity both in vitro and in vivo
M. Victoria Barbado et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis
Suzanne Nielsen et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Cannabis and Cannabinoids for Chronic Pain
E. Alfonso Romero-Sandoval et al.
CURRENT RHEUMATOLOGY REPORTS (2017)
A selective review of medical cannabis in cancer pain management
Alexia Blake et al.
ANNALS OF PALLIATIVE MEDICINE (2017)
Chemical Profiling of Medical Cannabis Extracts
Melissa M. Lewis et al.
ACS OMEGA (2017)
Cannabis Roots: A Traditional Therapy with Future Potential for Treating Inflammation and Pain
Natasha R. Ryz et al.
CANNABIS AND CANNABINOID RESEARCH (2017)
Delta-9-Tetrahydrocannabinol/Cannabidiol Oromucosal Spray (Sativex®): A Review in Multiple Sclerosis-Related Spasticity
Gillian M. Keating
DRUGS (2017)
Medical cannabis and mental health: A guided systematic review
Zach Walsh et al.
CLINICAL PSYCHOLOGY REVIEW (2017)
A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment
Robert J. Tait et al.
CLINICAL TOXICOLOGY (2016)
Neuropathic Pain Components in Patients with Cancer: Prevalence, Treatment, and Interference with Daily Activities
Anne Oosterling et al.
PAIN PRACTICE (2016)
Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization
Sonia Hernandez-Tiedra et al.
AUTOPHAGY (2016)
The Role of Cannabinoids in Neuroanatomic Alterations in Cannabis Users
Valentina Lorenzetti et al.
BIOLOGICAL PSYCHIATRY (2016)
Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review
Samantha J. Broyd et al.
BIOLOGICAL PSYCHIATRY (2016)
Cannabidiol rather than Cannabis sativa extracts inhibit cell growth and induce apoptosis in cervical cancer cells
Sindiswa T. Lukhele et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
Impact of chemotherapy-induced nausea and vomiting on health-related quality of life and resource utilization: A systematic review
Silvia Sommariva et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
A user's guide to cannabinoid therapies in oncology
V. Maida et al.
CURRENT ONCOLOGY (2016)
Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Regulation of Tumor Progression
Christopher J. Coke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis
Marieke H. J. van den Beuken-van Everdingen et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2016)
Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics
Megan Brafford May et al.
CANCER MANAGEMENT AND RESEARCH (2016)
In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma
T. Fisher et al.
CURRENT ONCOLOGY (2016)
Marijuana use and use disorders in adults in the USA, 2002-14: analysis of annual cross-sectional surveys
Wilson M. Compton et al.
LANCET PSYCHIATRY (2016)
Chronic Cannabinoid Receptor 2 Activation Reverses Paclitaxel Neuropathy Without Tolerance or Cannabinoid Receptor 1-Dependent Withdrawal
Liting Deng et al.
BIOLOGICAL PSYCHIATRY (2015)
Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study
Moshe Yeshurun et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stem-like cells proliferation by inducing autophagy in a TRPV2-dependent manner
Massimo Nabissi et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
In vitro and in vivo evaluation of Δ9-tetrahidrocannabinol/PLGA nanoparticles for cancer chemotherapy
L. Martin-Banderas et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Cannabinoids for Medical Use A Systematic Review and Meta-analysis
Penny F. Whiting et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Cannabis use and mania symptoms: A systematic review and meta-analysis
Melanie Gibbs et al.
JOURNAL OF AFFECTIVE DISORDERS (2015)
Effects of Cannabinoids on T-cell Function and Resistance to Infection
Toby K. Eisenstein et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2015)
Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer
Mohamad Elbaz et al.
MOLECULAR ONCOLOGY (2015)
Safety and Toxicology of Cannabinoids
Jane Sachs et al.
NEUROTHERAPEUTICS (2015)
Role of Psychosocial Variables on Chemotherapy-Induced Nausea and Vomiting and Health-Related Quality of Life among Cancer Patients: A European Study
Luigi Grassi et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2015)
Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma
E. Singer et al.
CELL DEATH & DISEASE (2015)
Positive allosteric modulators of the μ-opioid receptor: a novel approach for future pain medications
N. T. Burford et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
How Cannabis Causes Paranoia: Using the Intravenous Administration of a†9-Tetrahydrocannabinol (THC) to Identify Key Cognitive Mechanisms Leading to Paranoia
Daniel Freeman et al.
SCHIZOPHRENIA BULLETIN (2015)
Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study
Marta Di Forti et al.
LANCET PSYCHIATRY (2015)
Adverse Cardiovascular, Cerebrovascular, and Peripheral Vascular Effects of Marijuana Inhalation: What Cardiologists Need to Know
Grace Thomas et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1
Maria Haustein et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer
Ryuichi Murase et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Antidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis sativa
Alexandre R. de Mello Schier et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2014)
Allosteric Modulation of a Cannabinoid G Protein-coupled Receptor BINDING SITE ELUCIDATION AND RELATIONSHIP TO G PROTEIN SIGNALING
Derek M. Shore et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human breast cancer cells
Shuso Takeda et al.
JOURNAL OF TOXICOLOGICAL SCIENCES (2014)
The Combination of Cannabidiol and Δ9-Tetrahydrocannabinol Enhances the Anticancer Effects of Radiation in an Orthotopic Murine Glioma Model
Katherine A. Scott et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery
Elizabeth J. Rahn et al.
MOLECULAR PAIN (2014)
Inflammation Based Regulation of Cancer Cachexia
Jill K. Onesti et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Marijuana use and long-term mortality among survivors of acute myocardial infarction
Lauren Frost et al.
AMERICAN HEART JOURNAL (2013)
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms
Luciano De Petrocellis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents
Massimo Nabissi et al.
CARCINOGENESIS (2013)
Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity
Vicky Katsidoni et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Preparation and characterization of Δ9-tetrahydrocannabinol-loaded biodegradable polymeric microparticles and their antitumoral efficacy on cancer cell lines
Dolores Hernan Perez de la Ossa et al.
JOURNAL OF DRUG TARGETING (2013)
COX-2 and PPAR-γ Confer Cannabidiol-Induced Apoptosis of Human Lung Cancer Cells
Robert Ramer et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Local Delivery of Cannabinoid-Loaded Microparticles Inhibits Tumor Growth in a Murine Xenograft Model of Glioblastoma Multiforme
Dolores Hernan Perez de la Ossa et al.
PLOS ONE (2013)
The Pharmacologic and Clinical Effects of Medical Cannabis
Laura M. Borgelt et al.
PHARMACOTHERAPY (2013)
Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators
Iain Brown et al.
PROGRESS IN LIPID RESEARCH (2013)
A global toxicogenomic analysis investigating the mechanistic differences between tobacco and marijuana smoke condensates in vitro
Rebecca M. Maertens et al.
TOXICOLOGY (2013)
Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells
I. Dando et al.
CELL DEATH & DISEASE (2013)
Ceramide and Apoptosis: Exploring the Enigmatic Connections between Sphingolipid Metabolism and Programmed Cell Death
Thomas D. Mullen et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2012)
The Therapeutic Potential of Cannabis and Cannabinoids
Franjo Grotenhermen et al.
DEUTSCHES ARZTEBLATT INTERNATIONAL (2012)
Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1
Robert Ramer et al.
FASEB JOURNAL (2012)
Synthetic cannabinoid and marijuana exposures reported to poison centers
M. B. Forrester et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2012)
Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer
Gabriella Aviello et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2012)
Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial
Russell K. Portenoy et al.
JOURNAL OF PAIN (2012)
Grey matter alterations associated with cannabis use: Results of a VBM study in heavy cannabis users and healthy controls
Janna Cousijn et al.
NEUROIMAGE (2012)
Towards the use of cannabinoids as antitumour agents
Guillermo Velasco et al.
NATURE REVIEWS CANCER (2012)
CB1 and CB2 receptor agonists promote analgesia through synergy in a murine model of tumor pain
Iryna A. Khasabova et al.
BEHAVIOURAL PHARMACOLOGY (2011)
Cannabis-related hospitalizations: unexpected serious events identified through hospital databases
Emilie Jouanjus et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials
Mary E. Lynch et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy
D. Vara et al.
CELL DEATH AND DIFFERENTIATION (2011)
SPICE GIRLS: SYNTHETIC CANNABINOID INTOXICATION
Aaron B. Schneir et al.
JOURNAL OF EMERGENCY MEDICINE (2011)
A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma
Sofia Torres et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Cannabidiol Induces Programmed Cell Death in Breast Cancer Cells by Coordinating the Cross-talk between Apoptosis and Autophagy
Ashutosh Shrivastava et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Cannabinoids attenuate cancer pain and proliferation in a mouse model
Negin Saghafi et al.
NEUROSCIENCE LETTERS (2011)
Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1
Robert Ramer et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Impact of cannabidiol on the acute and psychotomimetic effects of smoked cannabis: naturalistic study
Celia J. A. Morgan et al.
BRITISH JOURNAL OF PSYCHIATRY (2010)
The Dual Effects of δ9-Tetrahydrocannabinol on Cholangiocarcinoma Cells: Anti-Invasion Activity at Low Concentration and Apoptosis Induction at High Concentration
Surang Leelawat et al.
CANCER INVESTIGATION (2010)
Effects of cannabis on lung function: a population-based cohort study
R. J. Hancox et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients with Intractable Cancer-Related Pain
Jeremy R. Johnson et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2010)
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
Maria M. Caffarel et al.
MOLECULAR CANCER (2010)
Cannabidiol Enhances the Inhibitory Effects of Delta(9)-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival
Jahan P. Marcu et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Decrease of Plasminogen Activator Inhibitor-1 May Contribute to the Anti-Invasive Action of Cannabidiol on Human Lung Cancer Cells
Robert Ramer et al.
PHARMACEUTICAL RESEARCH (2010)
TRB3 links ER stress to autophagy in cannabinoid anti-tumoral action
Maria Salazar et al.
AUTOPHAGY (2009)
Δ9-Tetrahydrocannabinol suppresses vomiting behavior and Fos expression in both acute and delayed phases of cisplatin-induced emesis in the least shrew
Andrew P. Ray et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Depression as a Predictor of Disease Progression and Mortality in Cancer Patients
Jillian R. Satin et al.
CANCER (2009)
Modulation of Δ9-tetrahydrocannabinol-induced MCF-7 breast cancer cell growth by cyclooxygenase and aromatase
Shuso Takeda et al.
TOXICOLOGY (2009)
Cannabinoids and appetite: Food craving and food pleasure
Tim C. Kirkham
INTERNATIONAL REVIEW OF PSYCHIATRY (2009)
Loss of cannabinoid receptor 1 accelerates intestinal tumor growth
Dingzhi Wang et al.
CANCER RESEARCH (2008)
A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions
David Moir et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
Major depression after breast cancer: a review of epidemiology and treatment
Jesse R. Fann et al.
GENERAL HOSPITAL PSYCHIATRY (2008)
Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1
Robert Ramer et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Δ9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo
A. Preet et al.
ONCOGENE (2008)
Cannabidiol as a novel inhibitor of ld-1 gene expression in aggressive breast cancer cells
Sean D. McAllister et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Cannabinoids elicit antidepressant-like Behavior and activate Serotonergic neurons through the medial prefrontal cortex
Francis Rodriguez Bambico et al.
JOURNAL OF NEUROSCIENCE (2007)
Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral Δ9-tetrahydrocannabinol in rats
Tiziana Rubino et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Cannabis tea revisited: A systematic evaluation of the cannabinoid composition of cannabis tea
Arno Hazekamp et al.
JOURNAL OF ETHNOPHARMACOLOGY (2007)
Synergy between Δ9-tetrahydrocannabinol and morphine in the arthritic rat
Melinda L. Cox et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Cannabidiol - Recent advances
Raphael Mechoulam et al.
CHEMISTRY & BIODIVERSITY (2007)
The toxicology of cannabis and cannabis prohibition
Franjo Grotenhermen
CHEMISTRY & BIODIVERSITY (2007)
Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma
Alessia Ligresti et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: A multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the cannabis-in-cachexia-study-group
Florian Strasser et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
A pilot clinical study of Δ9- tetrahydrocannabinol in patients with recurrent glioblastoma multiforme
M. Guzman et al.
BRITISH JOURNAL OF CANCER (2006)
Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes
Arkaitz Carracedo et al.
CANCER RESEARCH (2006)
Δ9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation
Maria M. Caffarel et al.
CANCER RESEARCH (2006)
History of cannabis as a medicine:: a review
Antonio Waldo Zuardi
REVISTA BRASILEIRA DE PSIQUIATRIA (2006)
The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells
A Carracedo et al.
CANCER CELL (2006)
Enhancement of transdermal fentanyl and buprenorphine antinociception by transdermal Δ9-tetrahydrocannabinol
DL Cichewicz et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in rats
D Pascual et al.
PAIN (2005)
Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells
SD McAllister et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
Δ-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response
RJ McKallip et al.
JOURNAL OF IMMUNOLOGY (2005)
Delta 9-tetrahydrocannabinol increases C6 glioma cell death produced by oxidative stress
I Goncharov et al.
NEUROSCIENCE (2005)
Cannabinoids induce cancer cell proliferation via tumor necrosis factor α-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor
S Hart et al.
CANCER RESEARCH (2004)
Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines
P Massi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats
EM Marco et al.
BEHAVIOURAL PHARMACOLOGY (2004)
Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas
C Blázquez et al.
CANCER RESEARCH (2004)
A comparative analysis of the potential of cannabinoids and ondansetron to suppress cisplatin-induced emesis in the Suncus murinus (house musk shrew)
M Kwiatkowska et al.
PSYCHOPHARMACOLOGY (2004)
Topical cannabinoid enhances topical morphine antinociception
O Yesilyurt et al.
PAIN (2003)
Δ9-tetrahydrocannabinol selectively acts on CB1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets
MD Van Sickle et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2003)
A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain
LJ Kehl et al.
PAIN (2003)
Involvement of the κ-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats
S Marín et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2003)
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study
L Arseneault et al.
BRITISH MEDICAL JOURNAL (2002)
Involvement of the opioid system in the anxiolytic-like effects induced by Δ9-tetrahydrocannabinol
F Berrendero et al.
PSYCHOPHARMACOLOGY (2002)
Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis
GA McMahon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The cannabinoid agonist WIN55,212-2 suppresses opioid-induced emesis in ferrets
II Simoneau et al.
ANESTHESIOLOGY (2001)
Serum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viability
SOP Jacobsson et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Δ-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway
LX Zhu et al.
JOURNAL OF IMMUNOLOGY (2000)
Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation
I Galve-Roperh et al.
NATURE MEDICINE (2000)